313 related articles for article (PubMed ID: 7788260)
21. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
22. The prognostic importance of the nucleolar organizer region (AgNOR), Ki-67 and proliferating cell nuclear antigen (PCNA) in primary nonurachal bladder adenocarcinoma.
Ozdemir BH; Ozdemir OG; Sertçelik A
APMIS; 2001 Jun; 109(6):428-34. PubMed ID: 11506474
[TBL] [Abstract][Full Text] [Related]
23. Growth fractions in bladder cancer defined by Ki67: association with cancer grade, category and recurrence rate of superficial lesions.
Stavropoulos NE; Ioackim-Velogianni E; Hastazeris K; Kitsiou E; Stefanaki S; Agnantis N
Br J Urol; 1993 Nov; 72(5 Pt 2):736-9. PubMed ID: 8281405
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.
Bol MG; Baak JP; Rep S; Marx WL; Kruse AJ; Bos SD; Kisman O; Voorhorst FJ
Urology; 2002 Dec; 60(6):1124-30. PubMed ID: 12475695
[TBL] [Abstract][Full Text] [Related]
25. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
27. 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
Waldman FM; Carroll PR; Cohen MB; Kerschmann R; Chew K; Mayall BH
Mod Pathol; 1993 Jan; 6(1):20-4. PubMed ID: 8093979
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
29. Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.
Goyal S; Singh UR; Sharma S; Kaur N
Urol J; 2014 Mar; 11(1):1238-47. PubMed ID: 24595931
[TBL] [Abstract][Full Text] [Related]
30. Validation of silver-stained nucleolar organizer regions for evaluation of invasive character of urinary bladder carcinoma in rats and mice.
Iwata H; Otoshi T; Takada N; Murai T; Tamano S; Watanabe T; Katsura Y; Fukushima S
Urol Res; 1995; 23(1):27-32. PubMed ID: 7618232
[TBL] [Abstract][Full Text] [Related]
31. [Growth fractions of bladder cancer determined by proliferating cell nuclear antigen immunostaining].
Kuroda H; Yasunaga Y; Takatera H; Fujioka H; Ohnishi A; Tsujimoto M
Hinyokika Kiyo; 1994 May; 40(5):379-82. PubMed ID: 7912881
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic study of cell proliferative markers ki67, PCNA and p53 oncoprotein in bladder tumors].
Ben Rejeb A; Mahjoub A; Berraies N; Tissaoui K
Ann Urol (Paris); 2000 Aug; 34(4):240-8. PubMed ID: 10994143
[TBL] [Abstract][Full Text] [Related]
33. Lack of prognostic value of nucleolar organizer region enumeration in transitional cell carcinoma of the bladder.
Mansour P; Crocker J; Newman J
Arch Pathol Lab Med; 1990 Dec; 114(12):1261. PubMed ID: 1701296
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody.
Mazerolles C; Rishmann P; Chopin D; Popov Z; Malavaud B; Selves J; Neulat-Duga I; Bellot J; Delsol G
Histopathology; 1994 Dec; 25(6):563-8. PubMed ID: 7698733
[TBL] [Abstract][Full Text] [Related]
35. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
[TBL] [Abstract][Full Text] [Related]
36. [Monoclonal antibodies (MIB 1, PC 10, 486p and p53) as prognostic factors for recurrent urothelial carcinoma of the urinary bladder].
Hake R; Vorreuther R; Borchmann P; Lukowsky S; Thiele J; Fischer R
Verh Dtsch Ges Pathol; 1993; 77():236-40. PubMed ID: 7511288
[TBL] [Abstract][Full Text] [Related]
37. Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks.
Bol MG; Baak JP; van Diermen B; Buhr-Wildhagen S; Janssen EA; Kjellevold KH; Kruse AJ; Mestad O; Øgreid P
J Clin Pathol; 2003 Jun; 56(6):447-52. PubMed ID: 12783972
[TBL] [Abstract][Full Text] [Related]
38. Improved objectivity of grading of T(A,1) transitional cell carcinomas of the urinary bladder by quantitative nuclear and proliferation related features.
Bol MG; Baak JP; de Bruin PC; Rep S; Marx W; Bos S; Kisman O
J Clin Pathol; 2001 Nov; 54(11):854-9. PubMed ID: 11684720
[TBL] [Abstract][Full Text] [Related]
39. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
Lipponen PK; Eskelinen MJ
Br J Cancer; 1992 Jul; 66(1):171-6. PubMed ID: 1353364
[TBL] [Abstract][Full Text] [Related]
40. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
